semaglutide and tirzepatide compound Overview of Addressing the Weight Loss Injectable

Preclinical data suggests that chronic pain may cause significant changes in hippocampal plasticity, including a reduction of new neurons in the hippocampus (a portion of the brain related to learning, memory, mood regulation, and stress response.) It has previously been believed that a person is born with a finite number of neurons which will deteriorate over time

At 80 kilograms (about 176 pounds) that is 96 to 128 grams a day versus a 64-gram baseline

Many patients experience significantly reduced food and fluid intake, which decreases the volume of intestinal contents and reduces the stimulus for bowel movements

This anti-inflammatory action reduces tissue damage and encourages recovery

More importantly, we need to stop accepting weight gain from psychiatric medications as inevitable